Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apheresis.

D J Wallace, J R Klinenberg

    Disease-A-Month : DM
    |June 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Therapeutic apheresis has few absolute indications, including hyperviscosity syndrome and thrombotic thrombocytopenic purpura. Its broader use remains experimental, but research in component separation and antibody removal shows promise for future patient care.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.

    Annals of the rheumatic diseases·2021
    Same author

    Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities.

    Annals of the rheumatic diseases·2020
    Same author

    Geographic access to buprenorphine prescribers for patients who use public transit.

    Journal of substance abuse treatment·2020
    Same author

    Body image mediates the impact of pain on depressive symptoms in patients with systemic lupus erythematosus.

    Lupus·2019
    Same author

    Psychometric validation of the Arthritis Helplessness Index in systemic lupus erythematosus.

    Lupus·2018
    Same author

    Less than 7 hours of sleep per night is associated with transitioning to systemic lupus erythematosus.

    Lupus·2018
    Same journal

    Disturbances due to cold.

    Disease-a-month : DM·2026
    Same journal

    GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

    Disease-a-month : DM·2026
    Same journal

    GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

    Disease-a-month : DM·2026
    Same journal

    Periodontal disease and diabetic kidney disease: A comprehensive analysis.

    Disease-a-month : DM·2026
    Same journal

    Foreword for Glucagon-like peptide-1 receptor agonists (GLP-1) and its promise for potential benefits.

    Disease-a-month : DM·2026
    Same journal

    Foreword for insulin autoimmune syndrome (Hirata Disease): An updated review of epidemiology, pathophysiology, clinical features, diagnosis, and management.

    Disease-a-month : DM·2026
    See all related articles

    Area of Science:

    • Medical Science
    • Clinical Medicine
    • Immunology

    Background:

    • Therapeutic apheresis is an emerging medical treatment.
    • Established indications are limited but critical for specific conditions.

    Purpose of the Study:

    • To review the current applications and future potential of therapeutic apheresis.
    • To highlight the experimental nature of apheresis in many disorders.

    Main Methods:

    • Review of existing literature and clinical applications of therapeutic apheresis.
    • Discussion of specific component separation and antibody removal techniques.

    Main Results:

    • Absolute indications for apheresis include hyperviscosity syndrome, cryoglobulinemia, thrombotic thrombocytopenic purpura, Goodpasture's syndrome, and refractory immunologic disorders.

    Related Experiment Videos

  • Apheresis use in other conditions is largely experimental and requires careful consideration.

    • Conclusions:

    • While current apheresis applications are specific, its future potential is significant.
    • Ongoing research in component separation and antibody removal may revolutionize patient management and disease understanding.